Only a rare population of AML cells enriched for LSCs, characterized by a CD34+CD38− phenotype is capable of generating leukemia in immunodeficient mice.11 More recently, evidence has been presented for a clinically relevant population of leukemic cells CD34+CD38− in AML. This evidence concerns the gene CD34 and leukemia.